With world-class expertise in ctDNA analysis, Inivata is committed to partnering with pharmaceutical and biotech companies to accelerate clinical research to aid development of targeted therapies and immuno-oncology drugs and improve patient outcomes.
Inivata is partnering via three approaches
Best in class commercially available liquid biopsy tests for NSCLC and applicable to other cancer types (breast, melanoma, ovarian, pancreatic, colorectal, esophageal plus others)
Personalized assays with exceptional sensitivity
Custom panels applicable to other cancer types